Bangladeshi (DSE) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Jun 12, 2024

Explore the Bangladeshi (DSE) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

AMBEEPHA

Ambee Pharmaceuticals
৳690.000%31.2%৳1.7bn/aPE157.3xn/a0.2%

ORIONPHARM

Orion Pharma
৳70.800%-11.1%৳16.6bn/aPE36.4xn/a1.4%

ACTIVEFINE

Active Fine Chemicals
৳14.800%-23.3%৳3.6bn/aPS2.6xn/a0.2%

RENATA

Renata
৳622.900%-48.9%৳71.4b৳1,109.00PE31.1xE29.0%1.0%

ACMELAB

ACME Laboratories
৳63.800%-24.9%৳13.5bn/aPE5.6xn/a5.2%

SILCOPHL

Silco Pharmaceuticals
৳17.200%-28.9%৳1.8bn/aPE41.8xn/a1.7%

ASIATICLAB

Asiatic Laboratories
৳55.500%n/a৳6.8bn/an/an/an/a

BEACONPHAR

Beacon Pharmaceuticals
৳149.500%-39.0%৳34.5bn/aPE74.1xn/a1.1%

BXPHARMA

Beximco Pharmaceuticals
৳102.000%-30.2%৳45.5b৳177.50PE8.5xE15.6%3.4%

IBP

Indo-Bangla Pharmaceuticals
৳13.300%-21.8%৳1.5bn/aPS7.3xn/a0%

AFCAGRO

AFC Agro Biotech
৳13.600%-42.1%৳1.6bn/aPE1959xn/a0.4%

IBNSINA

IBN SINA Pharmaceutical Industry
৳230.500%-19.6%৳7.2b৳390.00PE10.4xE19.2%2.6%

SQURPHARMA

Square Pharmaceuticals
৳198.900%-5.2%৳176.3b৳321.75PE8.7xE13.3%5.3%

ORIONINFU

Orion Infusion
৳458.400%40.4%৳9.3bn/aPE218.5xn/a0.2%

NAVANAPHAR

Navana Pharmaceuticals
৳87.800%-23.1%৳9.4bn/aPE21.4xn/a1.5%

LIBRAINFU

Libra Infusions
৳616.600%37.8%৳1.4bn/an/an/a0.2%

CENTRALPHL

Central Pharmaceuticals
৳20.700%84.8%৳2.5bn/aPS22.2xn/a0%

ADVENT

Advent Pharma
৳25.000%-13.2%৳2.3bn/aPE25.2xn/a0.8%

SILVAPHL

Silva Pharmaceuticals
৳16.100%-25.5%৳2.2bn/aPS3.6xn/a0.6%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.